Here are the latest quarterly results of India's top pharmaceuticals companies. For more detailed updates, read our pharmaceuticals sector report and check the latest pharmaceuticals sector stock quotes.
Click on title to sort | Mar 2012 | Mar 2013 | YoY %-Change | Get More Info | ||||
---|---|---|---|---|---|---|---|---|
Name | Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (%) |
PAT (%) |
P/E* (x) |
|
AJANTA PHARMA | 1,761 | 236 | 2,494 | 271 | 41.6% | 14.8% | 25.4 | More Info
|
BROOKS LAB | 145 | 25 | 223 | 54 | 54.0% | 117.2% | 112.2 | More Info
|
DR. REDDYS LAB | 26,585 | 3,416 | 33,399 | 5,683 | 25.6% | 66.4% | 81.7 | More Info
|
GENNEX LAB. | 59 | 4 | 84 | 3 | 42.2% | -24.3% | 7.0 | More Info
|
GUJ.THEMIS. | 54 | 49 | 73 | -0 | 36.6% | -100.9% | 52.3 | More Info
|
IPCA LABS | 5,611 | 766 | 6,717 | 754 | 19.7% | -1.5% | 79.4 | More Info
|
J.B.CHEMICALS | 1,548 | 89 | 2,051 | 198 | 32.5% | 122.8% | 26.8 | More Info
|
MAKERS LAB. | 125 | -2 | 163 | 10 | 31.1% | N.A. | 22.2 | More Info
|
NATURAL CAPS | 120 | 10 | 136 | 26 | 13.3% | 164.0% | 43.2 | More Info
|
NEWTIME INFRASTRUCTURE | 2 | 1 | 0 | 0 | -77.0% | -90.0% | 172.9 | More Info
|
PANCHSHEEL ORG | 99 | 9 | 80 | 0 | -19.3% | -99.0% | 8.0 | More Info
|
SCANDENT IMAGING | 0 | 0 | 6 | 1 | N.A. | 2,575.0% | N.A. | More Info
|
SHUKRA PHARMA | 4 | -75 | 16 | -24 | 257.0% | N.A. | 13.2 | More Info
|
SUVEN LIFE SCIENCES | 625 | 83 | 747 | 86 | 19.5% | 3.9% | N.A. | More Info
|
SYNCOM FORMULATIONS | 269 | -8 | 348 | 11 | 29.4% | N.A. | 10.7 | More Info
|
THEMIS MEDICARE | 347 | -51 | 253 | -43 | -26.9% | N.A. | 94.3 | More Info
|
TORRENT PHARMA | 6,740 | -10 | 8,710 | 1,110 | 29.2% | N.A. | 52.0 | More Info
|
VISTA PHARMA | 15 | -1 | 18 | 1 | 16.6% | N.A. | N.A. | More Info
|
VIVANZA BIOSCIENCES | 0 | -0 | 0 | -5 | N.A. | N.A. | 7,284.5 | More Info
|
WOCKHARDT | 11,756 | -1,977 | 14,855 | 3,348 | 26.4% | N.A. | N.A. | More Info
|
WOCKHARDT | 11,756 | -1,977 | 14,855 | 3,348 | 26.4% | N.A. | N.A. | More Info
|
Sector Aggregate | 67,620 | 586 | 85,229 | 14,831 | 26.0% | 2,432.9% | ||
* Trailing 12 months earnings, excluding extraordinary / exceptional items. |
Dec 2012 Results | Jun 2013 Results | Latest Quarter Results | View All Results |